Roivant Sciences (ROIV) Return on Equity [ROE] (2021 - 2026)
Roivant Sciences (ROIV) posted Return on Equity [ROE] of -8.12% for fiscal Q1 2027 (quarter ended Jun 30, 2026), up 5.64 percentage points from -13.76% a year earlier but down 0.37 percentage points from the prior quarter.
Powered by 
Analysis
Roivant Sciences (ROIV) Return on Equity [ROE] (2021 - 2026) Analysis & Trends
For FY2026 (ended Mar 31, 2026), Roivant Sciences' Return on Equity [ROE] came in at -7.59%, down 1.46 percentage points from FY2025.
- Annual Return on Equity [ROE] shows a four-year change of +37.72 percentage points (FY2022 to FY2026).
- In prior fiscal years, Roivant Sciences' Return on Equity [ROE] was -6.13% in FY2025 (-111.18 pp), 105.04% in FY2024 (+166.22 pp), -61.18% in FY2023 (-15.86 pp) and -45.32% in FY2022.
- Quarterly Return on Equity [ROE] has run from a low of -91.52% in fiscal Q3 2023 to a high of 111.20% in fiscal Q3 2024 over five years.
- On a year-over-year basis, Return on Equity [ROE] increased in two of the last eight quarters, with an average year-over-year change of -27.46 percentage points.
- The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was fiscal Q3 2024, with a gain of 202.72 percentage points; the weakest was fiscal Q3 2025, with a drop of 116.37 percentage points.
- According to Business Quant data, Return on Equity [ROE] for the three prior fiscal quarters was -7.75% (Q4 2026), -20.57% (Q3 2026) and -11.94% (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Roivant Sciences | 26.43 Bn | 27.12 Bn | 1.16 Mn | -8.12% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -8.12% |
| Mar 31, 2026 | -7.75% |
| Dec 31, 2025 | -20.57% |
| Sep 30, 2025 | -11.94% |
| Jun 30, 2025 | -13.76% |
| Mar 31, 2025 | -6.65% |
| Dec 31, 2024 | -5.16% |
| Sep 30, 2024 | 81.35% |
| Jun 30, 2024 | 74.80% |
| Mar 31, 2024 | 64.93% |
| Dec 31, 2023 | 111.20% |
| Sep 30, 2023 | -79.66% |
| Jun 30, 2023 | -70.99% |
| Mar 31, 2023 | -70.52% |
| Dec 31, 2022 | -91.52% |
| Sep 30, 2022 | -77.51% |
| Jun 30, 2022 | -62.03% |
| Mar 31, 2022 | -43.12% |
| Dec 31, 2021 | -51.16% |
| Sep 30, 2021 | -53.15% |
API Access
Roivant Sciences Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ROIV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "ROIV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ROIV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();